A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain

NCT01345045 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

193

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathic Pain

Interventions

DRUG: ABT-639
DRUG: pregabalin
DRUG: Placebo

Sponsor

AbbVie (prior sponsor, Abbott)